▶ 調査レポート

多発性硬化症治療の世界市場:市場規模・現状・予測

• 英文タイトル:Global Multiple Sclerosis Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。多発性硬化症治療の世界市場:市場規模・現状・予測 / Global Multiple Sclerosis Treatment Market Size, Status and Forecast 2019-2025 / QYR9ST04959資料のイメージです。• レポートコード:QYR9ST04959
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、多発性硬化症治療の世界市場について調査・分析し、多発性硬化症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(免疫調節剤、免疫抑制剤)、用途別(獣医病院、獣医クリニック、研究機関)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の多発性硬化症治療市場動向
・主要企業別マーケットシェア
・多発性硬化症治療の種類別市場規模2014-2019
(免疫調節剤、免疫抑制剤)
・多発性硬化症治療の用途別市場規模2014-2019
(獣医病院、獣医クリニック、研究機関)
・多発性硬化症治療の北米市場:主要企業・種類別/用途別市場規模
・多発性硬化症治療のヨーロッパ市場:主要企業・種類別/用途別市場規模
・多発性硬化症治療の中国市場:主要企業・種類別/用途別市場規模
・多発性硬化症治療の日本国内市場:主要企業・種類別/用途別市場規模
・多発性硬化症治療の東南アジア市場:主要企業・種類別/用途別市場規模
・多発性硬化症治療のインド市場:主要企業・種類別/用途別市場規模
・多発性硬化症治療の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Teva Pharmaceutical Industries、Bayer、Biogen Idec、Pfizer、Novartis)
・多発性硬化症治療の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Specific symptoms can include double vision, blindness in one eye, muscle weakness, trouble with sensation, or trouble with coordination. MS takes several forms, with new symptoms either occurring in isolated attacks (relapsing forms) or building up over time (progressive forms). Between attacks, symptoms may disappear completely; however, permanent neurological problems often remain, especially as the disease advances.Although there is no known cure for multiple sclerosis, several therapies have proven helpful. The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. Starting medications is generally recommended in people after the first attack when more than two lesions are seen on MRI.
In 2018, the global Multiple Sclerosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Multiple Sclerosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multiple Sclerosis Treatment development in United States, Europe and China.

The key players covered in this study
Teva Pharmaceutical Industries
Bayer
Biogen Idec
Pfizer
Novartis

Market segment by Type, the product can be split into
Immunomodulators
Immunosuppressant

Market segment by Application, split into
Veterinary Hospitals
Veterinary Clinics
Research Institutions

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Multiple Sclerosis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Multiple Sclerosis Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Multiple Sclerosis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Multiple Sclerosis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Immunomodulators
1.4.3 Immunosuppressant
1.5 Market by Application
1.5.1 Global Multiple Sclerosis Treatment Market Share by Application (2014-2025)
1.5.2 Veterinary Hospitals
1.5.3 Veterinary Clinics
1.5.4 Research Institutions
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Multiple Sclerosis Treatment Market Size
2.2 Multiple Sclerosis Treatment Growth Trends by Regions
2.2.1 Multiple Sclerosis Treatment Market Size by Regions (2014-2025)
2.2.2 Multiple Sclerosis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Multiple Sclerosis Treatment Market Size by Manufacturers
3.1.1 Global Multiple Sclerosis Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Multiple Sclerosis Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Multiple Sclerosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Multiple Sclerosis Treatment Key Players Head office and Area Served
3.3 Key Players Multiple Sclerosis Treatment Product/Solution/Service
3.4 Date of Enter into Multiple Sclerosis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Multiple Sclerosis Treatment Market Size by Type (2014-2019)
4.2 Global Multiple Sclerosis Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Multiple Sclerosis Treatment Market Size (2014-2019)
5.2 Multiple Sclerosis Treatment Key Players in United States
5.3 United States Multiple Sclerosis Treatment Market Size by Type
5.4 United States Multiple Sclerosis Treatment Market Size by Application

6 Europe
6.1 Europe Multiple Sclerosis Treatment Market Size (2014-2019)
6.2 Multiple Sclerosis Treatment Key Players in Europe
6.3 Europe Multiple Sclerosis Treatment Market Size by Type
6.4 Europe Multiple Sclerosis Treatment Market Size by Application

7 China
7.1 China Multiple Sclerosis Treatment Market Size (2014-2019)
7.2 Multiple Sclerosis Treatment Key Players in China
7.3 China Multiple Sclerosis Treatment Market Size by Type
7.4 China Multiple Sclerosis Treatment Market Size by Application

8 Japan
8.1 Japan Multiple Sclerosis Treatment Market Size (2014-2019)
8.2 Multiple Sclerosis Treatment Key Players in Japan
8.3 Japan Multiple Sclerosis Treatment Market Size by Type
8.4 Japan Multiple Sclerosis Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Multiple Sclerosis Treatment Market Size (2014-2019)
9.2 Multiple Sclerosis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Multiple Sclerosis Treatment Market Size by Type
9.4 Southeast Asia Multiple Sclerosis Treatment Market Size by Application

10 India
10.1 India Multiple Sclerosis Treatment Market Size (2014-2019)
10.2 Multiple Sclerosis Treatment Key Players in India
10.3 India Multiple Sclerosis Treatment Market Size by Type
10.4 India Multiple Sclerosis Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Multiple Sclerosis Treatment Market Size (2014-2019)
11.2 Multiple Sclerosis Treatment Key Players in Central & South America
11.3 Central & South America Multiple Sclerosis Treatment Market Size by Type
11.4 Central & South America Multiple Sclerosis Treatment Market Size by Application

12 International Players Profiles
12.1 Teva Pharmaceutical Industries
12.1.1 Teva Pharmaceutical Industries Company Details
12.1.2 Company Description and Business Overview
12.1.3 Multiple Sclerosis Treatment Introduction
12.1.4 Teva Pharmaceutical Industries Revenue in Multiple Sclerosis Treatment Business (2014-2019)
12.1.5 Teva Pharmaceutical Industries Recent Development
12.2 Bayer
12.2.1 Bayer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Multiple Sclerosis Treatment Introduction
12.2.4 Bayer Revenue in Multiple Sclerosis Treatment Business (2014-2019)
12.2.5 Bayer Recent Development
12.3 Biogen Idec
12.3.1 Biogen Idec Company Details
12.3.2 Company Description and Business Overview
12.3.3 Multiple Sclerosis Treatment Introduction
12.3.4 Biogen Idec Revenue in Multiple Sclerosis Treatment Business (2014-2019)
12.3.5 Biogen Idec Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Multiple Sclerosis Treatment Introduction
12.4.4 Pfizer Revenue in Multiple Sclerosis Treatment Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Multiple Sclerosis Treatment Introduction
12.5.4 Novartis Revenue in Multiple Sclerosis Treatment Business (2014-2019)
12.5.5 Novartis Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Multiple Sclerosis Treatment Key Market Segments
Table Key Players Multiple Sclerosis Treatment Covered
Table Global Multiple Sclerosis Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Multiple Sclerosis Treatment Market Size Market Share by Type 2014-2025
Figure Immunomodulators Figures
Table Key Players of Immunomodulators
Figure Immunosuppressant Figures
Table Key Players of Immunosuppressant
Table Global Multiple Sclerosis Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Veterinary Hospitals Case Studies
Figure Veterinary Clinics Case Studies
Figure Research Institutions Case Studies
Figure Multiple Sclerosis Treatment Report Years Considered
Table Global Multiple Sclerosis Treatment Market Size 2014-2025 (Million US$)
Figure Global Multiple Sclerosis Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Multiple Sclerosis Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Multiple Sclerosis Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Multiple Sclerosis Treatment Market Share by Regions 2014-2019
Figure Global Multiple Sclerosis Treatment Market Share by Regions 2014-2019
Figure Global Multiple Sclerosis Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Multiple Sclerosis Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Multiple Sclerosis Treatment Market Share by Manufacturers (2014-2019)
Figure Global Multiple Sclerosis Treatment Market Share by Manufacturers in 2018
Table Global Multiple Sclerosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Multiple Sclerosis Treatment Product/Solution/Service
Table Date of Enter into Multiple Sclerosis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Multiple Sclerosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Multiple Sclerosis Treatment Market Size Share by Type (2014-2019)
Figure Global Multiple Sclerosis Treatment Market Size Market Share by Type (2014-2019)
Table Global Multiple Sclerosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Multiple Sclerosis Treatment Market Size Share by Application (2014-2019)
Figure Global Multiple Sclerosis Treatment Market Size Market Share by Application (2014-2019)
Figure Global Multiple Sclerosis Treatment Revenue Market Share by Application in 2018
Figure United States Multiple Sclerosis Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Multiple Sclerosis Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Multiple Sclerosis Treatment Market Share (2018-2019)
Table United States Multiple Sclerosis Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Multiple Sclerosis Treatment Market Share by Type (2014-2019)
Table United States Multiple Sclerosis Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Multiple Sclerosis Treatment Market Share by Application (2014-2019)
Figure Europe Multiple Sclerosis Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Multiple Sclerosis Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Multiple Sclerosis Treatment Market Share (2018-2019)
Table Europe Multiple Sclerosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Multiple Sclerosis Treatment Market Share by Type (2014-2019)
Table Europe Multiple Sclerosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Multiple Sclerosis Treatment Market Share by Application (2014-2019)
Figure China Multiple Sclerosis Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Multiple Sclerosis Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Multiple Sclerosis Treatment Market Share (2018-2019)
Table China Multiple Sclerosis Treatment Market Size by Type (2014-20189) (Million US$)
Table China Multiple Sclerosis Treatment Market Share by Type (2014-2019)
Table China Multiple Sclerosis Treatment Market Size by Application (2014-2019) (Million US$)
Table China Multiple Sclerosis Treatment Market Share by Application (2014-2019)
Figure Japan Multiple Sclerosis Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Multiple Sclerosis Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Multiple Sclerosis Treatment Market Share (2018-2019)
Table Japan Multiple Sclerosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Multiple Sclerosis Treatment Market Share by Type (2014-2019)
Table Japan Multiple Sclerosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Multiple Sclerosis Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Multiple Sclerosis Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Multiple Sclerosis Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Multiple Sclerosis Treatment Market Share (2018-2019)
Table Southeast Asia Multiple Sclerosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Multiple Sclerosis Treatment Market Share by Type (2014-2019)
Table Southeast Asia Multiple Sclerosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Multiple Sclerosis Treatment Market Share by Application (2014-2019)
Figure India Multiple Sclerosis Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Multiple Sclerosis Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Multiple Sclerosis Treatment Market Share (2018-2019)
Table India Multiple Sclerosis Treatment Market Size by Type (2014-2019) (Million US$)
Table India Multiple Sclerosis Treatment Market Share by Type (2014-2019)
Table India Multiple Sclerosis Treatment Market Size by Application (2014-2019) (Million US$)
Table India Multiple Sclerosis Treatment Market Share by Application (2014-2019)
Figure Central & South America Multiple Sclerosis Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Multiple Sclerosis Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Multiple Sclerosis Treatment Market Share (2018-2019)
Table Central & South America Multiple Sclerosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Multiple Sclerosis Treatment Market Share by Type (2014-2019)
Table Central & South America Multiple Sclerosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Multiple Sclerosis Treatment Market Share by Application (2014-2019)
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Multiple Sclerosis Treatment Business (2014-2019) (Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Multiple Sclerosis Treatment Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Bayer Company Details
Table Bayer Revenue in Multiple Sclerosis Treatment Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Multiple Sclerosis Treatment Business (2014-2019)
Table Bayer Recent Development
Table Biogen Idec Company Details
Table Biogen Idec Revenue in Multiple Sclerosis Treatment Business (2014-2019)(Million US$)
Figure Biogen Idec Revenue Growth Rate in Multiple Sclerosis Treatment Business (2014-2019)
Table Biogen Idec Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Multiple Sclerosis Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Multiple Sclerosis Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Multiple Sclerosis Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Multiple Sclerosis Treatment Business (2014-2019)
Table Novartis Recent Development
Table Global Multiple Sclerosis Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Multiple Sclerosis Treatment Market Size Share by Regions (2019-2025)
Figure Global Multiple Sclerosis Treatment Market Size Share by Regions in 2025
Figure United States Multiple Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Multiple Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Multiple Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Multiple Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Multiple Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Multiple Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Multiple Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Multiple Sclerosis Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Multiple Sclerosis Treatment Market Size by Product (2019-2025)
Figure Global Multiple Sclerosis Treatment Market Size by Product in 2025
Table Global Multiple Sclerosis Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Multiple Sclerosis Treatment Market Size by Application (2019-2025)
Figure Global Multiple Sclerosis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources